Search Results - "Favret, M"

Adjuvant docetaxel and cyclophosphamide plus trastuzumab in patients with HER2 -amplified early stage breast cancer: a single-group, open-label, phase 2 study by Jones, Stephen E, Dr, Collea, Rufus, MD, Paul, Devchand, DO, Sedlacek, Scot, MD, Favret, Anne M, MD, Gore, Ira, MD, Lindquist, Deborah L, MD, Holmes, Frankie Ann, MD, Allison, Mary Ann K, MD, Brooks, Barry D, MD, Portillo, Raul M, MD, Vukelja, Svetislava J, MD, Steinberg, Michael S, MD, Stokoe, Christopher, MD, Crockett, Maria W, BS, Wang, Yunfei, PhD, Asmar, Lina, PhD, Robert, Nicholas J, MD, O'Shaughnessy, Joyce, MD

“…Summary Background Previous results suggest that docetaxel plus cyclophosphamide improves disease-free survival (DFS) and overall survival compared with…”
Get full text

Pre-clinical Mouse Models of Neurodegenerative Lysosomal Storage Diseases by Favret, Jacob M, Weinstock, Nadav I, Feltri, M Laura, Shin, Daesung

“…There are over 50 lysosomal hydrolase deficiencies, many of which cause neurodegeneration, cognitive decline and death. In recent years, a number of broad…”
Get full text

Facile Synthesis of Pyrrolyl-Containing Semisquaraines in Water as Precursors for Non-Symmetric Squaraines by Ta, Daniel D., Favret, Jeanne M., Dzyuba, Sergei V.

“…One-step reactions between squaric acid and pyrroles, such as 3-ethyl-2,4-dimethyl-pyrrole and 1,2,5-trimethylpyrrole, in water provide the corresponding…”
Get full text

Pegylated liposomal doxorubicin plus carboplatin in patients with metastatic breast cancer: a phase II study by Collea, R.P., Kruter, F.W., Cantrell, J.E., George, T.K., Kruger, S., Favret, A.M., Lindquist, D.L., Melnyk, A.M., Pluenneke, R.E., Shao, S.H., Crockett, M.W., Asmar, L., O’Shaughnessy, J.

“…We determined the objective response rates produced by pegylated liposomal doxorubicin (PLD) plus carboplatin with/without trastuzumab (Herceptin). Patients…”
Get full text

Ribociclib with letrozole vs letrozole alone in elderly patients with hormone receptor-positive, HER2-negative breast cancer in the randomized MONALEESA-2 trial by Sonke, Gabe S., Hart, Lowell L., Campone, Mario, Erdkamp, Frans, Janni, Wolfgang, Verma, Sunil, Villanueva, Cristian, Jakobsen, Erik, Alba, Emilio, Wist, Erik, Favret, Anne M., Bachelot, Thomas, Hegg, Roberto, Wheatley-Price, Paul, Souami, Farida, Sutradhar, Santosh, Miller, Michelle, Germa, Caroline, Burris, Howard A.

“…Purpose Determine the efficacy and safety of first-line ribociclib plus letrozole in elderly patients with HR+, HER2− advanced breast cancer. Methods 668…”
Get full text

Fertilizer response for hybrid and open-pollinated canola and economic optimal nutrient levels by Smith, Elwin G, Upadhyay, Bharat M, Favret, M. Lucila, Karamanos, Rigas E

“…Hybrid (HY) canola (Brassica napus L.) produces a higher seed yield than open-pollinated (OP) canola. While it is expected higher-yielding HY canola may…”
Get full text

Dose Delays, Dose Reductions, and Relative Dose Intensity in Patients With Cancer Who Received Adjuvant or Neoadjuvant Chemotherapy in Community Oncology Practices by Denduluri, Neelima, Patt, Debra A, Wang, Yunfei, Bhor, Menaka, Li, Xiaoyan, Favret, Anne M, Morrow, Phuong Khanh, Barron, Richard L, Asmar, Lina, Saravanan, Shanmugapriya, Li, Yanli, Garcia, Jacob, Lyman, Gary H

“…A wide variety of myelosuppressive chemotherapy regimens are used for the treatment of cancer in clinical practice. Neutropenic complications, such as febrile…”
Get more information

Phase Ib/IIa study of RX-5902, a novel orally bioavailable inhibitor of phosphorylated P68, which prevents nuclear β-catenin translocation in patients with triple negative breast cancer by Diamond, J.R., Andreopoulou, E., Favret, A.M., Nanda, R., Peterson, C., Benaim, E.

Get full text

HER2-Positive Advanced Breast Cancer by Robert, Nicholas J., MD, Favret, Anne M., MD

“…It is important when treating a patient who has advanced breast cancer to establish the biologic characteristics of the tumor. In addition to knowing the…”
Get full text

Segment 4 (the quadrate lobe): a barometer of cirrhotic liver disease at US by Lafortune, M, Matricardi, L, Denys, A, Favret, M, Déry, R, Pomier-Layrargues, G

“…To evaluate the dimensions of segment 4 of the liver in patients with cirrhosis by using ultrasonography (US). The transverse diameter of segment 4 was…”
Get more information

Cirrhosis of the liver : a regenerative process by CALLEA, F, BRISIGOTTI, M, FABBRETTI, G, SCIOT, R, VAN EYKEN, P, FAVRET, M

“…The ancient story of Prometheus, chained to a rock for defying Zeus by stealing fire from Mount Olympus and subjected to daily tearing at his liver by an…”
Get full text

Hepatitis C virus infection after renal transplantation: prevalence and course of morphologic lesions by Sandrini, S, Chiappini, R, Setti, G, Carli, O, Matricardi, L, Puoti, M, Callea, F, Favret, M, Maiorca, R

Get full text

Thuricin: the bacteriocin produced by Bacillus thuringiensis by Favret, M E, Yousten, A A

“…Bacillus thuringiensis serovar, thuringiensis (HD-2) demonstrated antibacterial activity against 48 of 56 strains of B. thuringiensis and against some other…”
Get more information

Intrahepatic Cholangiocarcinoma and Hepatitis C and B Virus Infection, Alcohol Intake, and Hepatolithiasis: A Case-Control Study in Italy by Donato, Francesco, Gelatti, Umberto, Tagger, Alessandro, Favret, Maurizio, Ribero, Maria Lisa, Callea, Francesco, Martelli, Claudia, Savio, Antonella, Trevisi, Paola, Nardi, Giuseppe

“…Objective: Intrahepatic cholangiocarcinoma (ICC) is a rare type of primary liver cancer (PLC) arising from intrahepatic bile ducts. We carried out a…”
Get full text

Liver Fibrosis Progression Is Related to CD4 Cell Depletion in Patients Coinfected with Hepatitis C Virus and Human Immunodeficiency Virus by Puoti, Massimo, Bonacini, Maurizio, Spinetti, Angiola, Putzolu, Valeria, Govindarajan, Sugantha, Zaltron, Serena, Favret, Maurizio, Callea, Francesco, Gargiulo, Francesco, Donato, Francesco, Carosi, Giampiero

“…A total of 204 patients with liver biopsy—proven hepatitis C virus (HCV) infection, 84 with and 120 without human immunodeficiency virus (HIV) coinfection,…”
Get full text

Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer by Hortobagyi, Gabriel N, Stemmer, Salomon M, Burris, Howard A, Yap, Yoon-Sim, Sonke, Gabe S, Paluch-Shimon, Shani, Campone, Mario, Blackwell, Kimberly L, André, Fabrice, Winer, Eric P, Janni, Wolfgang, Verma, Sunil, Conte, Pierfranco, Arteaga, Carlos L, Cameron, David A, Petrakova, Katarina, Hart, Lowell L, Villanueva, Cristian, Chan, Arlene, Jakobsen, Erik, Nusch, Arnd, Burdaeva, Olga, Grischke, Eva-Maria, Alba, Emilio, Wist, Erik, Marschner, Norbert, Favret, Anne M, Yardley, Denise, Bachelot, Thomas, Tseng, Ling-Ming, Blau, Sibel, Xuan, Fengjuan, Souami, Farida, Miller, Michelle, Germa, Caroline, Hirawat, Samit, O’Shaughnessy, Joyce

“…In patients with advanced HR-positive, HER2-negative breast cancer, the addition of the cyclin-dependent kinase inhibitor ribociclib to letrozole was…”
Get full text

Insecticidal activity of Bacillus laterosporus by Favret, M E, Yousten, A A

Get more information

Biosynthesis of thiopeptide antibiotic A10255: incorporation of isotopically-labeled precursors by Favret, M E, Paschal, J W, Elzey, T K, Boeck, L D

“…The biosynthetic origin of antibiotic A10255 was investigated using 14C- and 13C-labeled amino acids. DL-[1-(13)C]Serine labeled 15 of the 17 amino acid…”
Get more information

Biosynthesis of thiopeptide antibiotic A10255 in stirred reactors using a chemically defined medium supplemented with continuous nutrient feeds by Boeck, L D, Favret, M E, Wetzel, R W

“…A10255 is a complex of new thiopeptide antibiotics produced by Streptomyces gardneri. When stirred reactors were operated in batch mode using a defined medium…”
Get more information

Severe Hepatotoxicity During Combination Antiretroviral Treatment: Incidence, Liver Histology, and Outcome by Puoti, Massimo, Torti, Carlo, Ripamonti, Diego, Castelli, Francesco, Zaltron, Serena, Zanini, Barbara, Spinetti, Angiola, Putzolu, Valeria, Casari, Salvatore, Tomasoni, Lina, Quiros-Roldan, Eugenia, Favret, Maurizio, Berchich, Luisa, Grigolato, Piergiovanni, Callea, Francesco, Carosi, Giampiero

“…OBJECTIVES:To assess incidence, risk factors, histology, and outcome of severe hepatotoxicity (SH) during antiretroviral treatment (ART). METHODS:Seven hundred…”
Get full text